These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32602022)

  • 1. Assessment of left ventricular systolic function in hypertrophic cardiomyopathy patients with myocardial injury: a study based on layer-specific speckle tracking echocardiaography.
    Liu W; Zhang Y; Liu Y; Ma C; Yang J; Sun D
    Int J Cardiovasc Imaging; 2020 Nov; 36(11):2129-2137. PubMed ID: 32602022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
    Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Layer-specific speckle tracking analysis of left ventricular systolic function and synchrony in maintenance hemodialysis patients.
    Liu C; Yan ZN; Fan L; Huang J; Shen D; Song XT
    BMC Cardiovasc Disord; 2020 Jan; 20(1):126. PubMed ID: 32160879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular short-axis systolic function changes in patients with hypertrophic cardiomyopathy detected by two-dimensional speckle tracking imaging.
    Huang J; Yan ZN; Rui YF; Fan L; Liu C; Li J
    BMC Cardiovasc Disord; 2018 Jan; 18(1):13. PubMed ID: 29378516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Layer-specific myocardial function in asymptomatic cats with obstructive hypertrophic cardiomyopathy assessed using 2-dimensional speckle-tracking echocardiography.
    Suzuki R; Mochizuki Y; Yoshimatsu H; Niina A; Teshima T; Matsumoto H; Koyama H
    J Vet Intern Med; 2019 Jan; 33(1):37-45. PubMed ID: 30499128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial shortening in 3 orthogonal directions and its transmural variation in patients with nonobstructive hypertrophic cardiomyopathy.
    Okada K; Yamada S; Iwano H; Nishino H; Nakabachi M; Yokoyama S; Abe A; Ichikawa A; Kaga S; Nishida M; Hayashi T; Murai D; Mikami T; Tsutsui H
    Circ J; 2015; 79(11):2471-9. PubMed ID: 26354501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic myocardial strain identified in hypertrophic cardiomyopathy subjects with preserved left ventricular ejection fraction using a novel multi-layer transthoracic echocardiography technique.
    Ozawa K; Funabashi N; Takaoka H; Kamata T; Kanaeda A; Saito M; Nomura F; Kobayashi Y
    Int J Cardiol; 2015 Apr; 184():237-243. PubMed ID: 25723651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular systolic function changes in hypertrophic cardiomyopathy patients detected by the strain of different myocardium layers and longitudinal rotation.
    Huang J; Yan ZN; Fan L; Rui YF; Song XT
    BMC Cardiovasc Disord; 2017 Aug; 17(1):214. PubMed ID: 28768478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cardiac troponin I is related to increased left ventricular wall thickness, left ventricular dysfunction, and male gender in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Okawa M; Yamanaka S; Hirota T; Hoshikawa E; Hayato K; Yamasaki N; Matsumura Y; Yasuda N; Sugiura T; Doi YL
    Clin Cardiol; 2010 Feb; 33(2):E1-7. PubMed ID: 20043329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular and atrial functions in hypertrophic cardiomyopathy patients with very high LVOT gradient: a speckle tracking echocardiographic study.
    Tigen K; Sunbul M; Karaahmet T; Dundar C; Ozben B; Guler A; Cincin A; Bulut M; Sari I; Basaran Y
    Echocardiography; 2014 Aug; 31(7):833-41. PubMed ID: 24341920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic strain in hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy.
    Sun JP; Xu TY; Ni XD; Yang XS; Hu JL; Wang SC; Li Y; Bahler RC; Wang JG
    Echocardiography; 2019 Feb; 36(2):257-265. PubMed ID: 30561121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In patients with hypertrophic cardiomyopathy myocardial fibrosis is associated with both left ventricular and left atrial dysfunction.
    Prinz C; Van Buuren F; Bogunovic N; Bitter T; Faber L; Horstkotte D
    Acta Cardiol; 2012 Apr; 67(2):187-93. PubMed ID: 22641976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced speckle tracking echocardiography allowing a three-myocardial layer-specific analysis of deformation parameters.
    Adamu U; Schmitz F; Becker M; Kelm M; Hoffmann R
    Eur J Echocardiogr; 2009 Mar; 10(2):303-8. PubMed ID: 18801725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in left atrial myocardial dynamics during reservoir phase between hypertrophic cardiomyopathy and hypertensive heart determined using three-dimensional speckle tracking echocardiography.
    Yanagi Y; Okada K; Kaga S; Mikami T; Aiba M; Masauzi N; Murayama M; Tanemura A; Yokoyama S; Nishino H; Nakabachi M; Tamaki Y; Aoyagi H; Motoi K; Ishizaka S; Chiba Y; Tsujinaga S; Iwano H; Anzai T
    Int J Cardiovasc Imaging; 2022 Aug; 38(8):1781-1791. PubMed ID: 37726515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the left ventricular function in patients with uremia using layer-specific 2-dimensional speckle tracking echocardiography.
    Sun M; Dong Y; Wang Y; Li G; Huang D
    Medicine (Baltimore); 2019 Mar; 98(9):e14656. PubMed ID: 30817588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: comparison with essential hypertension.
    Badran HM; Faheem N; Ibrahim WA; Elnoamany MF; Elsedi M; Yacoub M
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1397-406. PubMed ID: 24094559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Global and Segmental Hypertrophy on Two-Dimensional Strain Derived from Three-Dimensional Echocardiography in Hypertrophic Cardiomyopathy: Comparison with Healthy Subjects.
    Voilliot D; Huttin O; Hammache N; Filippetti L; Vaugrenard T; Aliot E; Sadoul N; Juillière Y; Selton-Suty C
    J Am Soc Echocardiogr; 2015 Sep; 28(9):1093-102. PubMed ID: 25935111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular function in patients with hypertrophic cardiomyopathy and its relation to myocardial fibrosis and exercise tolerance.
    Maragiannis D; Alvarez PA; Ghosn MG; Chin K; Hinojosa JJ; Buergler JM; Shah DJ; Nagueh SF
    Int J Cardiovasc Imaging; 2018 Jan; 34(1):121-129. PubMed ID: 28748418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.